ML

Manohar Lal Chhabra

Active Director Director DIN 00487309
DIN 00487309 First appointment Mar 2005 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Mar 2005
Shareholding value •••• Premium profile

About Manohar Lal Chhabra

Data last updated:

Manohar Lal Chhabra has 21 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Tppl Pharmaceuticals Private Limited and Nutrica Nutraceuticals Private Limited. Formerly with 4 companies, such as Gnosis Pharmaceuticals Private Limited and Curosis Healthcare Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹8.08 Cr; the largest is Tppl Pharmaceuticals Private Limited at ₹6.69 Cr (FY 2025).

DIN 00487309
Primary Designation Director
First Appointment 17 Mar 2005
Oldest Company Age 14 yrs
Largest company Tppl Pharmaceuticals Private Limited · ₹6.69 Cr (FY 2025)
Combined revenue ₹8.08 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tppl Pharmaceuticals Private Limited U24232RJ2011PTC037198
Director11 May 20122011₹6.69 Cr (FY 2025)Active
Director06 Jun 20202020₹1.39 Cr (FY 2024)Active
Designated Partner30 Jul 20142014–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Mar 20052005₹88.76 Cr (FY 2024)Active
Curosis Healthcare Private Limited U24232GJ2011PTC145019
Director24 Nov 20112011₹19.23 Cr (FY 2024)Active
Director06 Feb 20142014–Strike Off
Director22 Feb 20132013–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Tppl Pharmaceuticals Private Limited
Nutrica Nutraceuticals Private Limited
Glutenfree Tours India Private Limited
Dr. Sid Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Manohar Lal Chhabra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manohar Lal Chhabra

Manohar Lal Chhabra has 21 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Tppl Pharmaceuticals Private Limited and Nutrica Nutraceuticals Private Limited. Formerly with 4 companies, such as Gnosis Pharmaceuticals Private Limited and Curosis Healthcare Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹8.08 Cr; the largest is Tppl Pharmaceuticals Private Limited at ₹6.69 Cr (FY 2025).

Manohar Lal Chhabra is associated with 3 companies as Director and Designated Partner, including Tppl Pharmaceuticals Private Limited (₹6.69 Cr), Dr. Sid Pharmaceutical Private Limited (₹1.39 Cr), Dr.Sid Laboratories Llp.

Manohar Lal Chhabra has expertise in General Business, Healthcare.

Manohar Lal Chhabra has 21 years in corporate governance.

By reported revenue, the largest current company of Manohar Lal Chhabra is Tppl Pharmaceuticals Private Limited, with revenue of ₹6.69 Cr (FY 2025).

The 2 current companies of Manohar Lal Chhabra that report revenue have a combined latest revenue of ₹8.08 Cr.

Manohar Lal Chhabra currently holds positions at 3 companies: Tppl Pharmaceuticals Private Limited (₹6.69 Cr), Dr. Sid Pharmaceutical Private Limited (₹1.39 Cr), Dr.Sid Laboratories Llp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available